Lampalizumab
Lampalizumab Basic information
- Product Name:
- Lampalizumab
- Synonyms:
-
- Lampalizumab
- Research Grade Lampalizumab (DHB88001)
- Research Grade Lampalizumab
- Lampalizumab (anti-Complement Factor D)
- CAS:
- 1278466-20-8
- MW:
- 0
- Mol File:
- Mol File
Lampalizumab Chemical Properties
- form
- Liquid
- color
- Colorless to light yellow
Lampalizumab Usage And Synthesis
Uses
Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research[1][2].
in vivo
Lampalizumab delivered intravenously to cynomolgus monkeys elicits nearly 10-fold increases in serum Factor D levels within five hours, effectively neutralizing its inhibitory activity[1].
References
[1] Yuan X, et al. Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. Haematologica. 2017 Mar;102(3):466-475. DOI:10.3324/haematol.2016.153312
[2] Hanus J, et al. Current therapeutic developments in atrophic age-related macular degeneration. Br J Ophthalmol. 2016 Jan;100(1):122-7. DOI:10.1136/bjophthalmol-2015-306972
LampalizumabSupplier
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- 027-65317797 15926423062
- 422450190@qq.com
- Tel
- 4008200310
- marketing@tsbiochem.com
- Tel
- 65279366 18108604356
- products@biolabreagent.com
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com